The global veterinary point of care diagnostics market was valued at USD 2,761 Million in 2024, and is projected to reach USD 5,010 Million by 2030. Veterinary point of care diagnostics refers to diagnostic tools and technologies that help in the early detection of diseases and on-site testing of health conditions that provide a real-time result, helping the veterinarians and farmers to make treatment decisions for the well-being of the animals. The rising population of both companion and livestock animals contributes to the increased demand for effective diagnostic tools.

The increasing prevalence of zoonotic and transboundary diseases further contributes to the market growth. For example, according to the report published by the NIH, about 60% of all known human infectious diseases are zoonotic, and around 75% of emerging infectious diseases are of animal origin. Also, the increasing prevalence of infectious diseases in companion animals, such as parvovirus, feline leukaemia, and heartworm, increases the demand for diagnostic tools that help in early diagnosis of the disease. Furthermore, there are stricter policies pertaining to the health of animals due to concerns regarding food security globally. These policies have led to the implementation of various animal health and wellness programs aimed at ensuring disease control. Regulatory authorities across the world are imposing strict policies to prevent the outbreak of animal-borne diseases by implementing stricter diagnosis and treatment policies, thus contributing to the overall market growth.

For more details, please visit: https://apeloconsulting.com/reports/